Work

I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer

Year: 2019

Type: article

Source: Current Breast Cancer Reports

DOI: 10.1007/s12609-019-00334-2

Authors: Haiyun Wang, Douglas Yee

Institutions: University of Minnesota, Masonic Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: Quantitative Imaging for Assessing Breast Cancer Response to Treatment, The I SPY 2.2 TRIAL: Evolving to Imaging and Molecular Biomarker Response Directed Adaptive Sequential Treatment to Optimize Breast Cancer Outcomes, Cancer Center Support Grant

OpenAlex ID: W2989861603

FWCI: 1.779

Cites: 40

Cited by: 178

Related to: 10